MET vs MIRA · P/E 13, rev $38.23B vs $41.1M cap
MetLife Inc (MET) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
MIRA does not have a complete income-statement cache yet.
MET currently screens at market cap $52.16B and trailing P/E 12.7. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the MET and MIRA stock pages for the full models.
Not investment advice.